Trial Profile
A single center, retrospective study of Levodopa-carbidopa intestinal gel in patients with advanced Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Sep 2016
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Adverse reactions; Therapeutic Use
- 26 Sep 2016 New trial record